Optimizing CD34+ Cell Genome Editing for Efficiency and HSPC Maintenance
CRISPR-Cas9 gene editing of human hematopoietic stem and progenitor (HSPC) cells holds great promise for disease treatment by cellular therapy and other methodologies. However, the variables that can affect treatment of relevant diseases in the real world are still being elucidated. A critical part of this involves implementing an optimized gene editing and cell culture methodology. In this webinar, Dr. Marta Walasek and Ms. Danielle Nguyen Truong describe tips and tricks for effective genome editing of CD34⁺ cells, methods to evaluate genome editing efficiency, as well as optimal pre- and post- editing culture conditions to maintain HSPC function and long-term editing effects.
Publish Date:
May 30, 2022
Related Multimedia
-
Gene Targeting in Hematopoietic Stem Cells for Basic and Translational Research
Publish Date: November 28, 2018 -
Optimized Workflows for High-Efficiency Genome Editing in Stem and Primary Cell Types
Publish Date: September 09, 2019 -
Considerations for High-Efficiency Genome Editing of Human Pluripotent Stem Cells
Publish Date: May 29, 2020
Explore Our Products
-
Mobilized Human Peripheral Blood CD34+ Cells, Frozen
Primary human cells, frozen -
cGMP medium, for culture and expansion of human hematopoietic cells -
Serum-free medium for culture and expansion of hematopoietic cells
